tradingkey.logo
tradingkey.logo
Suchen

Quest Diagnostics Inc

DGX
Zur Watchlist hinzufügen
209.880USD
0.0000.00%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
23.30BMarktkapitalisierung
22.79KGV TTM

mehr Informationen über Quest Diagnostics Inc Unternehmen

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Quest Diagnostics Inc Informationen

BörsenkürzelDGX
Name des UnternehmensQuest Diagnostics Inc
IPO-datumDec 17, 1996
CEODavis (James E)
Anzahl der mitarbeiter45000
WertpapierartOrdinary Share
GeschäftsjahresendeDec 17
Addresse500 Plaza Drive
StadtSECAUCUS
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07094
Telefon19735202700
Websitehttps://www.questdiagnostics.com/
BörsenkürzelDGX
IPO-datumDec 17, 1996
CEODavis (James E)

Führungskräfte von Quest Diagnostics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
47.59K
+2.40%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
30.71K
+3.72%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
27.44K
+4.16%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
18.32K
+6.24%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
15.50K
--
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
13.06K
+8.75%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
7.72K
+14.79%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
3.85K
+29.63%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
47.59K
+2.40%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
30.71K
+3.72%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
27.44K
+4.16%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
18.32K
+6.24%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Quest Diagnostics Inc?

Die fünf größten Anteilseigner von Quest Diagnostics Inc sind: Ms. Catherine T. (Cathy) Doherty

Wie viele Institutionen halten Anteile an Quest Diagnostics Inc (DGX)?

Mit Stand vom 2026Q1 halten 1896 Institutionen Anteile an Quest Diagnostics Inc, mit einem Gesamtmarktwert von etwa 110.61M, was 99.92% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -3157069.00 gestiegen.

Was ist die größte Einnahmequelle von Quest Diagnostics Inc?

Am 2026Q1 erzielte das Geschäft mit Routine clinical testing services für Quest Diagnostics Inc den höchsten Umsatz in Höhe von 5.96B, was 54.00% des Gesamtumsatzes entspricht.
KeyAI